Marrone Bio Innovations I...

NASDAQ: MBII · Real-Time Price · USD
0.80
-0.20 (-20.00%)
At close: Apr 24, 2025, 3:47 PM

Marrone Bio Innovations Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-7.6M -5.31M -4.95M -3.04M -3.26M
Depreciation & Amortization
1.19M 1.18M 1.15M 1.15M 1.09M
Stock-Based Compensation
822K 759K 796K 881K 915K
Other Working Capital
-3.22M 1.6M 1.75M 1.03M -710K
Other Non-Cash Items
-83K -793K 142K 317K -161K
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
-2.73M 779K 2.55M -556K -3.6M
Operating Cash Flow
-8.4M -3.39M -308K -1.25M -5.02M
Capital Expenditures
-198K -188K -361K -425K -119K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -750K
Investing Cash Flow
-198K -188K -361K -425K -869K
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.67M 8.16M -1.75M 213K 8.97M
Financial Cash Flow
-1.67M 8.16M -1.75M 213K 8.97M
Net Cash Flow
-10.26M 4.58M -2.42M -1.46M 3.08M
Free Cash Flow
-8.59M -3.58M -669K -1.67M -5.14M